Gerresheimer AG (SWX:GXI)
| Market Cap | 575.88M -77.7% |
| Revenue (ttm) | 2.11B +11.8% |
| Net Income | 21.85M -79.6% |
| EPS | 0.63 -79.6% |
| Shares Out | n/a |
| PE Ratio | 26.35 |
| Forward PE | 6.72 |
| Dividend | 0.04 (0.22%) |
| Ex-Dividend Date | Jun 6, 2025 |
| Volume | n/a |
| Average Volume | 50 |
| Open | n/a |
| Previous Close | 17.32 |
| Day's Range | n/a |
| 52-Week Range | 17.32 - 75.60 |
| Beta | n/a |
| RSI | 3.87 |
| Earnings Date | Feb 26, 2026 |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery progra... [Read more]
Financial Performance
In fiscal year 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.
Financial numbers in EUR Financial StatementsNews
Gerresheimer delays 2025 results release to June, stock to be removed from SDAX
Gerresheimer on Tuesday again deferred the release of 2025 financial statements to June, citing a probe into its business deals, a delay that is now set to cost the German medical products maker ...
EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Annual Report / Postponement of the publication Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 20...
EQS-Adhoc: Gerresheimer AG: BaFin announces expansion of audit of 2024 consolidated financial statements and initiation of audit of 2025 Half-Year Financial Report
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Results / Full year/Results / Half year Gerresheimer AG: BaFin announces expansion of audit of 2024 consolidated financial statements and initiation of audit...
EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distri...
Diamond Hill International Strategy Q4 2025 Portfolio Review
Diamond Hill International Strategy returned 3.87% (net of fees) and the MSCI ACWI ex USA Index returned 5.05%. Sumitomo Densetsu, a Japanese electrical contractor, benefited from a takeover bid by Da...
Oakmark International Small Cap Strategy Q4 2025 Portfolio Drivers & Decisions
The Oakmark International Small Cap Strategy's return was 1.64% (NET) for the reporting period. Konecranes stock price jumped as it reported earnings that exceeded market expectations. Metso delivered...
Gerresheimer Reschedules 2025 Financials & Starts Centor Sale
Gerresheimer faces delayed accounts, major write-downs and a planned divestment, yet still targets solid growth and margins in 2026 amid ongoing investigations.
EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Annual Report / Postponement of the publication/Mergers and Acquisitions / Sale of Business Units Gerresheimer AG reschedules publication of annual and conso...
Gerresheimer appoints Uwe Röhrhoff as new interim CEO
Medical equipment maker Gerresheimer said on Tuesday it had appointed Uwe Röhrhoff as interim CEO, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO by mutual agreeme...
Gerresheimer finds 2024 revenue-recognition issues after external probe
Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law firm into the recognition of revenue and profit from bill-and-hold agreements in...
Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDT Company Participants Guido Pickert - Head of Investor Relations Dietmar Siemssen - CEO, Chairman of the Management Board...
Gerresheimer's shares fall 11% after another outlook cut
Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.
Gerresheimer cuts 2025 outlook again as Q3 disappoints
German packaging and medical equipment maker Gerresheimer cut its 2025 guidance again on Wednesday, now expecting organic revenues to decline between 2-4% as third quarter results fell below expectati...
Gerresheimer shares tank as financial regulator suspects accounting flaws
Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations.
Gerresheimer CFO resigns unexpectedly, successor to take over from September
Gerresheimer Chief Financial Officer Bernd Metzner has resigned from his role and will leave the company on August 31, the German packaging and medical equipment maker said on Friday.
Activist investor wants review at Gerresheimer after taking stake
Active Ownership, a major shareholder in Gerresheimer , said on Thursday it saw major potential for value creation at the German packaging and medical equipment specialist and called for a strategic r...
Gerresheimer shares rise on plan to sell moulded glass business
Shares of German packaging and medical equipment maker Gerresheimer jumped around 4% in early trading on Tuesday after the company announced plans to sell its moulded glass business late on Monday.
Gerresheimer calls a halt to discussions on potential takeover
German packaging and medical equipment maker Gerresheimer has ended discussions on a potential sale of the company, it said on Wednesday evening.
Gerresheimer cuts its 2025 revenue outlook for second time
German packaging and medical equipment maker Gerresheimer cut its revenue guidance for 2025 for a second time on Thursday, seeing continued weak demand in the cosmetic and oral liquids markets.
AVI Calls for Changes at Gerresheimer
LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. ...
UK fund Asset Value Investor calls for changes at Gerresheimer
London-based investment fund Asset Value Investors has asked German medical packaging maker Gerresheimer to take steps to restore its market value, it said on Thursday.
Gerresheimer cuts guidance for 2025 citing weak demand
German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions fo...
Gerresheimer: Strong Growth Projections Make Stock Look Cheap
Gerresheimer's strategic shift to value-driven solutions in pharma packaging supports higher margins and justifies a premium valuation over traditional packaging peers. Despite a weak Q1 with net loss...
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ET Company Participants Guido Pickert - Vice President, Corporate Investor Relations Dietmar Siemssen - Chief Exec...
Gerresheimer's first-quarter results hit by low demand in moulded glass
German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe reve...